WHITEHAWK THERAPEUTICS, INC. Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
WHITEHAWK THERAPEUTICS, INC. (WHWK) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $9.90 million as of 2024-12-31, per its 10-K filed 2025-03-28.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2025-03-28
- 2024-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $9.90M.
- 2024-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $14.50M.
- 2023-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $25.30M.
- 2023-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $26.90M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2024-12-31 | $9.90M 10-K · filed 2025-03-28 |
| 2024-09-30 | $14.50M 10-Q · filed 2024-11-06 |
| 2023-12-31 | $25.30M 10-K · filed 2024-03-13 |
| 2023-09-30 | $26.90M 10-Q · filed 2023-11-08 |
| 2021-06-30 | $804.85K 10-Q · filed 2021-08-11 |
| 2021-03-31 | $1.13M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $1.46M 10-K · filed 2021-03-11 |
| 2020-09-30 | $1.78M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $2.11M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $2.20M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $2.31M 10-K · filed 2020-03-16 |
| 2019-09-30 | $5.31M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $5.96M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $6.68M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $3.87M 10-K · filed 2019-03-07 |
| 2018-09-30 | $4.57M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $5.15M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $2.79M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $3.52M 10-K · filed 2018-03-15 |
| 2017-09-30 | $201.22K 10-Q · filed 2017-11-13 |
| 2017-06-30 | $226.41K 10-Q · filed 2017-08-10 |
| 2017-03-31 | $264.82K 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |